FTC sues to block Edwards Lifesciences purchase of JenaValve

FTC sues to block Edwards Lifesciences purchase of JenaValve
Edwards Lifesciences gains amid takeover speculation
Edwards Lifesciences acquires early-stage TMVR company Innovalve
AtriCure gains amid report of Edwards Lifesciences interest
Edwards Lifesciences to spin off critical-care unit, sets $1B stock buyback
58.56BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US28176E1082
CUSIP
28176E108
Sector
Healthcare
Industry
Medical Devices
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
59.22
PEG Ratio
2.24
Book Value
18.87
Dividend Share
-
Dividend Yield
-
Earnings Share
1.72
Wall Street Target Price
113.83
EPS Estimate Current Year
3.01
EPS Estimate Next Year
3.40
EPS Estimate Current Quarter
0.7365
EPS Estimate Next Quarter
0.7064
Most Recent Quarter
-
Revenue TTM
6,674,699,776
Gross Profit TTM
5,207,499,776
EBITDA
2,094,700,032
Profit Margin
15.30%
Return On Assets TTM
8.77%
Return On Equity TTM
9.33%
Revenue Per Share TTM
11.545
Qtly Revenue Growth YOY
10.50%
Diluted Eps TTM
1.72
Qtly Earnings Growth YOY
6.70%
Trailing PE
59.22
Forward PE
29
Price Sales TTM
8.774
Price Book MRQ
5.3921
Enterprise Value Revenue
8
Enterprise Value EBITDA
31
29.04
0.00%46.87
-3.03%23.29
-2.56%42.10
-2.43%28.61
-2.42%80.84
-1.51%79.41
-1.30%309.53
-1.30%103.50
-0.81%100.15
-0.55%